For years, employers have been struggling with changing local and state marijuana laws and the impact on workplace drug screening programs. At least 33 states now allow medical use of marijuana and 11, plus Washington, D.C., also permit recreational use. Recently, we...
Featured posts
All posts
FMCSA Reports Recent Drug Testing Trends
Almost six months into the COVID-19 pandemic, the most recent Federal Motor Carriers Drug & Alcohol Clearinghouse report reflects both positive and negative trends for our industry and those committed to drug-free workplaces. June saw a 28 percent...
Alcohol Screening Safety During COVID-19
Numerous reports over the spring and summer have suggested that substance use disorders are on the rise as a result of the uncertainty, mental health challenges and isolation that are part and parcel of life during COVID-19. Excessive alcohol consumption is one of the...
Buyer Beware: CBD, THC and Drug Testing
Is CBD medicine or isn’t it? Is it safe? Can it impact a drug test result? Cannabis has been the focus of considerable debate, advocacy, and policy, generating both interest and misinformation. There is a great deal of uncertainty about cannabis and cannabinoid...
The Epidemic Within the Pandemic
Long before the coronavirus arrived in the United States, this country was already struggling with another health crisis: the opioid epidemic. As these two epidemics are colliding, experts fear that people vulnerable to opioid use disorders and those who employ them...
Questions to Answer When Choosing your Drug & Alcohol Testing Team
By Tracy BowlinDrug and Alcohol Program ManagerAir Evac Lifeteam No matter how comprehensive and well-thought-out your company’s drug and alcohol screening program is, its success – and ultimately the safety and reputation of your business – are at risk if...
The Business of Getting Back to Business: 6 Steps for Reopening During COVID-19
As we get ready to go back to work, businesses are facing new challenges and realities that are complicated by uncertainties about the progression of COVID-19. We know that it’s not just a matter of returning to normal. Continued social distancing, stringent cleaning...
The New Normal: How to ensure compliance during COVID-19
In recent weeks, the National Drug & Alcohol Screening Association (NDASA) has hosted a series of COVID-19 Townhall Discussions for its members in the drug and alcohol screening industry. The main takeaways from these meetings? Our members are passionate...
SAP Clearinghouse Questions & Answers
Since the launching of the new Federal Motor Carrier Safety Administration Drug and Alcohol Clearinghouse in January 2020 many questions have arisen about Clearinghouse processes and procedures. Everyone is committed to making the database work well for all...
NDASA Guidance and U.S. DOT Response to COVID-19
In light of recent reports that the Federal Motor Carriers Safety Administration (FMCSA) and other transportation modes are considering suspending random drug testing requirements during the COVID-19 health crisis, the National Drug and Alcohol Screening...